Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-05-30 20:55:54 UTC |
---|
HMDB ID | HMDB0000019 |
---|
Secondary Accession Numbers | - HMDB00019
- HMDB0004260
- HMDB04260
|
---|
Metabolite Identification |
---|
Common Name | alpha-Ketoisovaleric acid |
---|
Description | alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma. In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465 ). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development. |
---|
Structure | InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8) |
---|
Synonyms | Value | Source |
---|
2-Keto-3-methylbutyric acid | ChEBI | 2-Ketoisovaleric acid | ChEBI | 2-Ketovaline | ChEBI | 2-oxo-3-Methylbutanoic acid | ChEBI | 2-oxo-3-Methylbutyric acid | ChEBI | 2-Oxoisovaleric acid | ChEBI | 3-Methyl-2-oxobutanoate | ChEBI | 3-Methyl-2-oxobutyric acid | ChEBI | alpha-Keto-isovaleric acid | ChEBI | alpha-Ketovaline | ChEBI | alpha-oxo-beta-Methylbutyricacid | ChEBI | alpha-Oxoisovaleric acid | ChEBI | Dimethylpyruvic acid | ChEBI | Isopropylglyoxylic acid | ChEBI | 2-oxo-3-Methylbutanoate | Kegg | 2-Oxoisovalerate | Kegg | 2-Oxoisopentanoate | Kegg | 2-Keto-3-methylbutyrate | Generator | 2-Ketoisovalerate | Generator | 2-oxo-3-Methylbutyrate | Generator | 3-Methyl-2-oxobutanoic acid | Generator | 3-Methyl-2-oxobutyrate | Generator | a-Keto-isovalerate | Generator | a-Keto-isovaleric acid | Generator | alpha-Keto-isovalerate | Generator | Α-keto-isovalerate | Generator | Α-keto-isovaleric acid | Generator | a-Ketovaline | Generator | Α-ketovaline | Generator | a-oxo-b-Methylbutyricacid | Generator | Α-oxo-β-methylbutyricacid | Generator | a-Oxoisovalerate | Generator | a-Oxoisovaleric acid | Generator | alpha-Oxoisovalerate | Generator | Α-oxoisovalerate | Generator | Α-oxoisovaleric acid | Generator | Dimethylpyruvate | Generator | Isopropylglyoxylate | Generator | 2-Oxoisopentanoic acid | Generator | a-Ketoisovalerate | Generator | a-Ketoisovaleric acid | Generator | alpha-Ketoisovalerate | Generator | Α-ketoisovalerate | Generator | Α-ketoisovaleric acid | Generator | 2-Ketoisvaleric acid | HMDB | 2-oxo-3-Methyl-butyrate | HMDB | 3-Methyl-2-oxo-butanoate | HMDB | 3-Methyl-2-oxo-butanoic acid | HMDB | 3-Methyl-2-oxo-butyrate | HMDB | 3-Methyl-2-oxo-butyric acid | HMDB | 3-Methyl-2-oxobutinoate | HMDB | 3-Methyl-2-oxobutinoic acid | HMDB | a-Keto-b-methylbutyrate | HMDB | a-Keto-b-methylbutyric acid | HMDB | a-oxo-b-Methylbutyrate | HMDB | a-oxo-b-Methylbutyric acid | HMDB | alpha-Keto-beta-methylbutyrate | HMDB | alpha-Keto-beta-methylbutyric acid | HMDB | alpha-oxo-beta-Methylbutyrate | HMDB | alpha-oxo-beta-Methylbutyric acid | HMDB | Ketovaline | HMDB | alpha-Ketoisopentanoic acid | HMDB | alpha-Ketoisovaleric acid | Generator, MeSH |
|
---|
Chemical Formula | C5H8O3 |
---|
Average Molecular Weight | 116.1152 |
---|
Monoisotopic Molecular Weight | 116.047344122 |
---|
IUPAC Name | 3-methyl-2-oxobutanoic acid |
---|
Traditional Name | α-ketoisovalerate |
---|
CAS Registry Number | 759-05-7 |
---|
SMILES | CC(C)C(=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8) |
---|
InChI Key | QHKABHOOEWYVLI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Keto acids and derivatives |
---|
Sub Class | Short-chain keto acids and derivatives |
---|
Direct Parent | Short-chain keto acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Branched fatty acid
- Methyl-branched fatty acid
- Short-chain keto acid
- Alpha-keto acid
- Fatty acyl
- Alpha-hydroxy ketone
- Ketone
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Carbonyl group
- Hydrocarbon derivative
- Organic oxygen compound
- Organooxygen compound
- Organic oxide
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 31.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
alpha-Ketoisovaleric acid,1TMS,isomer #1 | CC(C)C(=O)C(=O)O[Si](C)(C)C | 1039.8 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,1TMS,isomer #2 | CC(C)=C(O[Si](C)(C)C)C(=O)O | 1112.5 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TMS,isomer #1 | CC(C)=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1228.7 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TMS,isomer #1 | CC(C)=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1230.3 | Standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TMS,isomer #1 | CC(C)=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1223.5 | Standard polar | 33892256 | alpha-Ketoisovaleric acid,1TBDMS,isomer #1 | CC(C)C(=O)C(=O)O[Si](C)(C)C(C)(C)C | 1270.2 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,1TBDMS,isomer #2 | CC(C)=C(O[Si](C)(C)C(C)(C)C)C(=O)O | 1366.8 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TBDMS,isomer #1 | CC(C)=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1654.9 | Semi standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TBDMS,isomer #1 | CC(C)=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1664.8 | Standard non polar | 33892256 | alpha-Ketoisovaleric acid,2TBDMS,isomer #1 | CC(C)=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1565.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-000i-9500000000-ff936b879a69b5d118f8 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-000i-8920000000-e37b37d64d43dcf763f0 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (1 MEOX; 1 TMS) | splash10-000i-9400000000-e3995acc4818a98d0f48 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (1 MEOX; 1 TMS) | splash10-0f79-9720000000-5d89487273e44ea61a68 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid EI-B (Non-derivatized) | splash10-000i-9700000000-209c737dcac7df2b198c | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid EI-B (Non-derivatized) | splash10-0f79-5920000000-759a2f01b4f52767ade2 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Non-derivatized) | splash10-000i-9500000000-ff936b879a69b5d118f8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Non-derivatized) | splash10-000i-8920000000-e37b37d64d43dcf763f0 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (Non-derivatized) | splash10-000i-9400000000-e3995acc4818a98d0f48 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (Non-derivatized) | splash10-0f79-9720000000-5d89487273e44ea61a68 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Non-derivatized) | splash10-000i-7900000000-7e325567183fb56996d5 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - alpha-Ketoisovaleric acid GC-EI-TOF (Non-derivatized) | splash10-0ufr-0930000000-be90b06add7135b4a539 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dl-9000000000-52f9d8fc8386e4c512fe | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (1 TMS) - 70eV, Positive | splash10-006x-9600000000-52aefdc997dac92c8459 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - alpha-Ketoisovaleric acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-9000000000-10ab58a33e9ca7dbace0 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-000i-9000000000-ad51ff01c94b6046ad64 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-014i-0900000000-9993174a7b1801b90ddb | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-00xr-9500000000-293818b81e0879b6feb2 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-00di-9000000000-75058f27a2178b9cf121 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-9000000000-4c20af39e8ee009d5278 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ , negative-QTOF | splash10-014i-0900000000-9993174a7b1801b90ddb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ , negative-QTOF | splash10-00xr-9500000000-1a58c6a6b4f5477dabdd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ , negative-QTOF | splash10-00di-9000000000-75058f27a2178b9cf121 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-cc4465a47e663be66df5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid LC-ESI-IT , negative-QTOF | splash10-00di-9100000000-19511890852fce513a02 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 20V, Positive-QTOF | splash10-00kf-9300000000-30d3bdfb6d38dbb8e101 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 40V, Positive-QTOF | splash10-000l-9000000000-879b6502ff380673b776 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 10V, Positive-QTOF | splash10-0159-9800000000-0cf4d3a0e7b3356995c6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 35V, Positive-QTOF | splash10-014o-9900000000-f35430a2eaea0d81df32 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 10V, Positive-QTOF | splash10-00r2-9400000000-21f8c3fae79161c82099 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 20V, Positive-QTOF | splash10-00dl-9000000000-5f25e41413738bb6b5d7 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 40V, Positive-QTOF | splash10-0006-9000000000-801af00dea93fcfd637d | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 10V, Negative-QTOF | splash10-01b9-8900000000-5185c7dfc72c25069904 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 20V, Negative-QTOF | splash10-00xs-9200000000-7e2a275a65197f96f5d7 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 40V, Negative-QTOF | splash10-0600-9000000000-0013e0ff06f9896a1337 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 10V, Negative-QTOF | splash10-01b9-6900000000-7f00871b074cbd9a42e6 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 20V, Negative-QTOF | splash10-06di-9400000000-6d56778068e11e4f8e85 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 40V, Negative-QTOF | splash10-0a4i-9000000000-b445e7fc67a8ff2bd3ba | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - alpha-Ketoisovaleric acid 10V, Positive-QTOF | splash10-006x-9000000000-733fb7227d2d053b112f | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Schaefer K, von Herrath D, Erley CM, Asmus G: Calcium ketovaline as new therapy for uremic hyperphosphatemia. Miner Electrolyte Metab. 1990;16(6):362-4. [PubMed:2089249 ]
- Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38. [PubMed:2026685 ]
- Livesey G, Lund P: Binding of branched-chain 2-oxo acids to bovine serum albumin. Biochem J. 1982 Apr 15;204(1):265-72. [PubMed:7115325 ]
- Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9. [PubMed:6422161 ]
- Chuang DT, Niu WL, Cox RP: Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects. Biochem J. 1981 Oct 15;200(1):59-67. [PubMed:6895847 ]
- Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7. [PubMed:9869358 ]
- Gallina DL, Dominguez JM, Hoschoian JC, Barrio JR: Maintenance of nitrogen balance in a young woman by substitution of -ketoisovaleric acid for valine. J Nutr. 1971 Sep;101(9):1165-7. [PubMed:5096137 ]
- Schauder P, Schroder K, Langenbeck U: Serum branched-chain amino and keto acid response to a protein-rich meal in man. Ann Nutr Metab. 1984;28(6):350-6. [PubMed:6393856 ]
- Tsuchiya H, Hashizume I, Tokunaga T, Tatsumi M, Takagi N, Hayashi T: High-performance liquid chromatography of alpha-keto acids in human saliva. Arch Oral Biol. 1983;28(11):989-92. [PubMed:6581765 ]
- Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, Lazarow A, Nissim I: Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005 Jun;135(6 Suppl):1531S-8S. [PubMed:15930465 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|